课题基金 / 基金详情

A portable diagnostic device that provides the accuracy of laboratory testing at the point of care.

A portable diagnostic device that provides the accuracy of laboratory testing at the point of care.
一种便携式诊断设备,可在护理点提供实验室测试的准确性。
批准号:
10066301
负责人:
金额:
$66.2万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我们大多数人都经历过焦急等待实验室检查结果的经历。无论是旅行前完成的Covid-19测试还是我们的医生进行的血液测试,实验室周转时间都会对日常生活产生重大影响。对于患有糖尿病等慢性疾病的人来说,这种压力性的延迟不仅更频繁,而且会阻碍重要的临床决策和药物治疗的变化。管理患者症状和监测治疗通常需要定期门诊预约和多次血液检查。一些诊断测试,称为床旁(POC)测试,可以在患者旁边真实的时间完成。结果可以很快得到,因此可以立即采取行动。常见的POC测试包括血糖和侧流Covid-19测试。然而,尽管POC测试的优势,许多诊断测试仍然需要自动化实验室仪器提供的准确性。Invitron正在开发一种新的便携式设备,将使准确的医疗诊断测试能够在护理点快速有效地进行。该设备只使用一小滴可以通过手指针刺收集的血液,就可以在医生办公室、药房甚至病人家中提供快速的检测结果。这将取代实验室测试的需要,以及沿着焦急等待结果和延误诊断和治疗。该项目由一位科学家(StuartWoodhead教授)领导,他共同发明了一种用于医学诊断测试的化学发光(发光)技术。该技术有助于实现极其灵敏和准确的测量,并已被世界领先的实验室仪器广泛采用。他的团队目前正在开发下一代技术,该技术将使基于化学发光的诊断的优势应用于直接在护理点进行的快速检测。
英文摘要
Most of us have experienced the anxious wait for laboratory test results. Whether it's a Covid-19 test completed before travel or a blood test carried out by our doctor, laboratory turn-around times can significantly impact on everyday life. For people living with chronic diseases like diabetes this stressful delay is not only more frequent but can hinder important clinical decisions and changes to medication. Managing patient symptoms and monitoring treatment often requires regular clinic appointments and numerous blood tests.Some diagnostic tests, known as Point of Care (POC) tests, can be completed next to the patient in real time. Results are available quickly and so can be acted on immediately. Common POC tests include blood glucose and lateral-flow Covid-19 tests. However, despite the advantages of POC testing, many diagnostic tests still require the accuracy provided by automated laboratory instruments.Invitron is developing a new portable device that will enable accurate medical diagnostic tests to be carried out quickly and efficiently at the Point of Care. Using just a small droplet of blood that can be collected by fingerstick, the device will provide rapid test results in doctors' offices, pharmacies and even patient homes. This will replace the need for laboratory testing, along with the anxious wait for results and delays to diagnosis and treatment.This project is led by a scientist (Prof. Stuart Woodhead) who co-invented a chemiluminescence (light-emitting) technology for use in medical diagnostic testing. The technology facilitates extremely sensitive and accurate measurements and has already been widely adopted in world-leading laboratory instruments. His team is now developing a next-generation technology that will enable the benefits of chemiluminescence based diagnostics to be applied in rapid tests carried out directly at the Point of Care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
  • 批准号:
    82372328
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    项盈
  • 依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
  • 批准号:
    82372014
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    魏伟军
  • 依托单位: